Bracco Targets Cell Therapy Manufacturing with Bead-Free Microbubble Cell Processing - Takeaways - MDSpire

Bracco Targets Cell Therapy Manufacturing with Bead-Free Microbubble Cell Processing

Bead-free microbubble approach aims to simplify cell selection and activation for scalable cell therapy manufacturing

  • February 13, 2026

  • 3 min

Share

  • 1

    Bracco Imaging is entering the cell therapy manufacturing market with a microbubble-based approach to replace magnetic beads.

  • 2

    The microbubble technology aims to reduce cellular stress and eliminate residual materials in cell processing.

  • 3

    Bracco's approach allows for both positive and negative selection strategies, enhancing immune cell subset isolation.

  • 4

    The company is building a dedicated cell therapy team and collaborating with partners to develop automated selection systems.

  • 5

    Bracco plans to manufacture the microbubble product at a new GMP-compliant facility in Geneva, targeting clinical use by 2027.

Original Source(s)

Bracco Targets Cell Therapy Manufacturing with Bead-Free Microbubble Cell Processing

  • February 13, 2026

Related Content

The Impact of Physical Activity Levels on Sexual Function in Breast Cancer Survivors: An Integrative Review

Sexual dysfunction is a lasting effect of treatment and can impact the quality of life of breast cancer survivors. This review examined the impact of different levels (none/low, moderate, and high) of physical activity on sexual outcomes in breast cancer survivors.

Multi-omics analysis identifies stemness-driven molecular subtypes, prognostic signature, epigenetic target APCDD1, and drug candidate Leflunomide in Wilms tumor

Integrative discovery and targeted proteomics elucidate the plasma exosomal landscape in thyroid disorders, with emphasis on papillary thyroid carcinoma complicating Hashimoto’s thyroiditis